Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Telmisartan FDC vs Telmisartan Tablets
NCT02276391Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of telmisartan in hypertension (HTN) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve from 0 to last quantifiable data point up to 72 hours and Maximum measured concentration up to 72 hours. Started Jul 2008; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02276391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02276391.